Assertio Holdings, Inc.
ASRT
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
28 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$0.72
Price+1.15%
$0.01
1Y
Price
Market Cap
$69.302m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years+36.0%
EBITDA Margin+23.1%
Net Profit Margin-9.6%
Free Cash Flow MarginRevenue
$137.352m
+9.9%
1y CAGR-3.5%
3y CAGR+7.5%
5y CAGREarnings
-$28.924m
-34.0%
1y CAGR-114.4%
3y CAGR+2078.6%
5y CAGREPS
-$0.31
-34.8%
1y CAGR-89.9%
3y CAGR+1649.2%
5y CAGRBook Value
$105.803m
$319.775m
Assets$213.972m
Liabilities$39.166m
DebtDebt to Assets
12.3%
6.6x
Debt to EBITDAFree Cash Flow
$13.334m
-49.5%
1y CAGR-44.3%
3y CAGR+299.7%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company